ALCOHOL AND ALCOHOLISM is a prominent peer-reviewed journal published by Oxford University Press that focuses on a range of topics within the fields of medicine, psychiatry, and toxicology. With an ISSN of 0735-0414 and an E-ISSN of 1464-3502, this journal has carved out a significant niche in the academic landscape since its inception in 1965 and is set to continue its critical role until 2024. Renowned for its rigorous research and scholarly contributions, it holds a respectable Q2 category ranking in 2023 across multiple domains, including Medicine (miscellaneous), Psychiatry and Mental Health, and Toxicology. The journal's Scopus rankings further reflect its impact, with commendable percentiles such as the 70th for Medicine (miscellaneous) and the 62nd for Psychiatry and Mental Health. While access is not open, the journal aims to advance knowledge and understanding of alcohol-related issues, making it an indispensable resource for researchers, health professionals, and students interested in the complexities of alcohol consumption and its effects on health and society.

Tobacco Induced Diseases is a leading open-access journal published by EUROPEAN PUBLISHING, dedicated to advancing research in the critical fields of tobacco-related health issues, epidemiology, and public policy. With an ISSN of 1617-9625, this esteemed journal has been nurturing academic discourse since its inception in 2002, situated in the picturesque backdrop of Heraklion, Crete. Recognized for its rigorous publication standards and impactful contributions, the journal proudly holds a Q1 ranking in Health (Social Science) and consistently ranks within the top quarters for both Medicine (Miscellaneous) and Public Health, Environmental, and Occupational Health. With impressive Scopus rankings, including #67 in Health and #99 in Medicine, it serves as an essential platform for researchers, professionals, and students aiming to understand and address the pressing challenges associated with tobacco use and its long-term health implications. As the journal converges its research coverage from 2009 to 2024, it invites contributions that span multidisciplinary perspectives and innovative approaches to tackling tobacco-induced diseases.

DRUG AND ALCOHOL REVIEW, published by Wiley, is a leading journal dedicated to advancing the scholarship in the fields of drug and alcohol research. Since its inception in 1989, this esteemed publication has provided a critical platform for the dissemination of innovative research findings, reviews, and theoretical papers, addressing pressing issues in substance use and addiction. With an impact factor that places it in the Q1 category in both Health (social science) and Medicine (miscellaneous), it ranks #78 out of 371 in the Scopus index for Health and #115 out of 398 in Medicine, reflecting its significant influence and high citation rates among scholars. The journal is committed to fostering a multidisciplinary approach, integrating perspectives from psychology, sociology, public health, and medicine, to inform policy and practice. Accessible to researchers and practitioners alike, *DRUG AND ALCOHOL REVIEW* serves as an essential resource for anyone invested in understanding and addressing the complexities of drug and alcohol use in society.

The Journal of Mental Health and Human Behaviour is a distinguished publication dedicated to advancing the field of mental health, focusing on innovative research and practical applications that enhance human behaviour and overall well-being. Published by WOLTERS KLUWER MEDKNOW PUBLICATIONS, this journal has been an open-access platform since 2014, enabling wider dissemination of knowledge and fostering collaboration among researchers, professionals, and students globally. With an ISSN of 0971-8990 and E-ISSN 2543-1897, it aims to provide a comprehensive array of peer-reviewed articles that cover various facets of mental health, including psychological theories, therapeutic practices, and sociocultural influences. The journal plays an integral role in bridging the gap between research and practice, making it essential for those who are committed to improving mental health outcomes and advocating for human behaviour change. Published in India, the journal not only highlights regional issues but also contributes to international discussions on mental health trends and interventions, affirming its importance in a rapidly evolving field.

JOURNAL OF ADDICTIVE DISEASES, published by ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD, serves as a pivotal platform for researchers, clinicians, and students in the realms of clinical psychology, psychiatry, and addiction studies. With a distinguished history dating back to its inception in 1991, this journal spans critical research developments with its current scope covering converged years from 2018 to 2024, ensuring a robust repository of knowledge. Notably, it holds a respectable impact factor and is categorized in Q2 quartiles across several disciplines including Clinical Psychology, Medicine (miscellaneous), and Psychiatry and Mental Health for 2023, reflecting its impactful contributions to the scientific community. Despite the journal not currently offering Open Access, it remains highly ranked, occupying positions in the top percentiles of Scopus rankings. This journal emphasizes the importance of disseminating high-quality research focused on addictive behaviors and diseases, thereby addressing vital clinical and public health challenges.

Alkoholizm i Narkomania - Alcoholism and Drug Addiction is a prominent peer-reviewed journal published by the Institute of Psychiatry and Neurology, Department of Studies on Alcoholism in Warsaw, Poland. Renowned for its commitment to advancing the fields of addiction research and mental health, this journal disseminates critical findings regarding the prevention, treatment, and societal implications of alcoholism and drug addiction. Since becoming Open Access in 2017, it ensures that researchers, professionals, and students from across the globe have unrestricted access to valuable resources and emerging studies within this vital area of public health. The journal emphasizes innovative methodologies and interdisciplinary approaches, inviting contributions that explore the complex interplay of psychological, social, and biological factors influencing addiction. By fostering a collaborative and inclusive scholarly community, Alkoholizm i Narkomania aims to contribute significantly to the understanding and resolution of addiction-related challenges worldwide.

Psychology of Addictive Behaviors, published by the Educational Publishing Foundation of the American Psychological Association, is a distinguished peer-reviewed journal dedicated to advancing the understanding of addiction through rigorous psychological research. With an impressive impact factor and a reputation for excellence, this journal holds a prestigious Q1 quartile ranking in Clinical Psychology, Medicine (miscellaneous), and Psychiatry and Mental Health as of 2023. Since its inception in 1993, it has provided a vital platform for the dissemination of high-quality studies, fostering collaboration and knowledge exchange amidst researchers, clinicians, and students in the mental health arena. The journal is particularly noted for its comprehensive coverage of diverse topics related to addictive behaviors, thereby contributing significantly to the field's evidence base and clinical practices. Although currently not open access, its commitment to scholarly excellence ensures that subscribers benefit from invaluable insights into the complexities of addiction. With the culmination of research spanning from 1993 to 2024, Psychology of Addictive Behaviors stands as a cornerstone for those striving to understand and combat the challenges of addiction.

American Journal of Drug and Alcohol Abuse is a highly regarded publication in the field of substance abuse research, published by Taylor & Francis Inc. With its inception in 1974, this journal has become an essential resource for scholars and practitioners interested in clinical psychology, psychiatry, and the multifaceted issues surrounding drug and alcohol use. It holds a notable Q2 ranking in Clinical Psychology, Medicine (miscellaneous), and Psychiatry and Mental Health, emphasizing its impact and relevance in these domains. The journal's 2023 Scopus rankings further highlight its standing, placing it in the top quartile of publications with established readership and citation metrics. Researchers and students can benefit from its comprehensive articles that delve into the complexities of substance use, treatment methodologies, and the socio-psychological underpinnings of addiction. Whether you seek to access cutting-edge studies or contribute to ongoing discourse in the field, the American Journal of Drug and Alcohol Abuse serves as a vital hub for knowledge dissemination and scholarly engagement.

The Journal of Dual Diagnosis, published by Routledge Journals, Taylor & Francis Ltd, is a leading interdisciplinary platform dedicated to the critical study of co-occurring mental health and substance use disorders. With its ISSN 1550-4263 and E-ISSN 1550-4271, this esteemed journal has been at the forefront of advancing research and clinical practice since its inception in 2004, and continues to serve as a vital resource until 2024. Ranked in the second quartile (Q2) in Psychiatry and Mental Health and positioned at the 64th percentile in the Scopus rankings, it emphasizes the importance of integrating care across various domains of health. Although not open access, it offers a wealth of peer-reviewed articles, case studies, and reviews suitable for researchers, practitioners, and students alike, aiming to enhance our understanding and treatment of dual diagnosis. The journal's commitment to addressing the complexities of dual disorders not only informs research but also shapes policy and clinical guidelines, making it an essential read for anyone involved in these critical areas of mental health.

EXPERIMENTAL AND CLINICAL PSYCHOPHARMACOLOGY, published by the American Psychological Association, stands as a pivotal resource within the fields of pharmacology and psychiatry. With an ISSN of 1064-1297 and an E-ISSN of 1936-2293, this journal contributes significantly to the understanding of psychopharmacological interventions through its rich array of research articles, reviews, and clinical studies. Classified within the Q2 category in both Pharmacology and Psychiatry and Mental Health, it reflects a solid standing in academic performance, evidenced by its rankings in Scopus, where it places within the top half of its categories. Spanning from 1993 to 2024, it seeks to provide an essential platform for the dissemination of knowledge and advancements that influence clinical practice and therapeutic approaches. Although not an open-access journal, its impact on the development of evidence-based psychopharmacological treatments cannot be overstated, making it a vital resource for researchers, clinically active professionals, and students eager to stay abreast of cutting-edge developments in mental health and pharmacology.